1. Horwitz, M.A., G. Harth, B.J. Dillon, and S. Malesa-Galic. 2000. Recombinant BCG vaccines expressing the Mycobacterium tuberculosis 30 kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl. Acad. Sci. (USA). 97:13853-13858.
2. Horwitz, M.A., B.-W.E. Lee, B.J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. (USA). 92:1530-1534.
4. Harth, G., B.-Y. Lee, J. Wang, D.L. Clemens, and M.A. Horwitz. 1996. Novel Insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect. Immun. 64:3038-3047.
5. Horwitz, M.A. and G. Harth. 2003. A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis. Infect. Immun. 71:1672-1679.
6. Harth, G., B.-Y. Lee and M.A. Horwitz. 1997. High-level heterologous expression and secretion in rapidly growing nonpathogenic mycobacteria of four major Mycobacterium tuberculosis extracellular proteins considered to be leading vaccine candidates and drug targets. Infect. Immun. 65:2321-2328.
7. Blander, S.J. and M.A. Horwitz. 1989. Vaccination with the major secretory protein of Legionella pneumophila induces cell mediated and protective immunity in a guinea pig model of Legionnaires' disease. J. Exp. Med. 169: 691 705.
8. Blander, S.J. and M.A. Horwitz. 1991. Vaccination with the major secretory protein of Legionella induces humoral and cell mediated immune responses and protective immunity across different serogroups of Legionella pneumophila and different species of Legionella. J. Immunol. 147:285 291.
9. Blander, S.J. and M.A. Horwitz. 1993. The major cytoplasmic membrane protein of Legionella pneumophila, a genus common antigen and member of the hsp 60 family of heat shock proteins, induces protective immunity in a guinea pig model of Legionnaires' disease. J. Clin. Invest. 91:717-723.